A family cluster of Chagas disease detected through selective screening of blood donors: A case report and brief review

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 26, Issue 3, 2015, Pages 158-161

  Mongeau Martin, Guillaume ^a   Ndao, Momar ^a,b   Libman, Michael ^a   Delage, Gilles ^c   Ward, Brian J ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c HÉMA QUÉBEC   (Canada)

Author keywords

Blood donor screening; Chagas disease; ELISA; PCR; RIPA; Vertical transmission

Indexed keywords

ADULT; BLOOD BANK; BLOOD DONOR; CASE REPORT; CHAGAS DISEASE; CHILE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; RADIOIMMUNOPRECIPITATION; REVIEW; SIBLING; TRYPANOSOMA CRUZI; VERTICAL TRANSMISSION;

EID: 84936851382     PISSN: 17129532     EISSN: 19181493     Source Type: Journal    
DOI: 10.1155/2015/628981     Document Type: Review

References (34)

1. Coura JR, Borges-Pereira J. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop 2010;115:5-13.
2. Shikanai-Yasuda MA, Carvalho NB. Oral transmission of Chagas disease. Clin Infect Dis 2012;54:845-52.
3. Andrade JP, Marin Neto JA, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: Executive summary. Arq Bras Cardiol 2011;96:434-42.
4. WHO Expert Committee. Control of Chagas disease. Brasilia: World Health Organization, 2002. World Health Organ Tech Rep Ser 905.
5. Otani MM, Vinelli E, Kirchhoff LV, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 2009;49:1076-82.
6. Schmunis GA, Yadon ZE. Chagas disease: A Latin American health problem becoming a world health problem. Acta Trop 2010;115:14-21.
7. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009;49:e52-4.
8. Nickerson P, Orr P, Schroeder ML, Sekla L, Johnston JB. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989;111:851-3.
9. Lane DJ, Sher G, Ward B, Ndao M, Leiby D, Hewlett B. Investigation of the second case of transfusion transmitted Chagas' disease in Canada. San Francisco: 42nd Annual Meeting of the American Society of Hematology, December 1 to 5, 2000.
10. Canadian Blood Services. Implementation of selective Chagas disease (Trypanosoma cruzi) antibody testing for at-risk blood donors. http://www.transfusionmedicine.ca/sites/transfusionmedicine/files/news/2010-Notice-CMAJ.pdf (Accessed October 20, 2013).
11. O'Brien SF, Scalia V, Goldman M, et al. Selective testing for Trypanosoma cruzi: The first year after implementation at Canadian Blood Services. Transfusion 2013;53:1706-13.
12. O'Brien SF, Scalia V, Goldman M, et al. Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: Seroprevalence of donors who answer "no" to risk questions. Transfusion 2014;54:863-9.
13. Hema-Québec. Chagas Disease - New selection criterion concerning Chagas disease. www.hema-quebec.qc.ca/donner/donde-sang/qui-peut-donner-du-sang/maladie-de-chagas.en.html (Accessed October 20, 2013).
14. Ndao M, Spithill TW, Caffrey R, et al. Identification of novel diagnostic serum biomarkers for Chagas' disease in asymptomatic subjects by mass spectrometric profiling. J Clin Microbiol 2010;48:1139-49.
15. Berrizbeitia M, Figueroa M, Ward BJ, et al. Development and application of an ELISA assay using excretion/secretion proteins from epimastigote forms of T. cruzi (ESEA antigens) for the diagnosis of Chagas disease. J Trop Med 2012;2012:875909.
16. Torrico F, Alonso-Vega C, Suarez E, et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 2004;70:201-9.
17. Apt W, Zulantay I, Arnello M, et al. Congenital infection by Trypanosoma cruzi in an endemic area of Chile: A multidisciplinary study. Trans R Soc Trop Med Hyg 2013;107:98-104.
18. Sánchez Negrette O, Mora MC, Basombrío MA. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 2005;115:e668-72.
19. Schofield CJ, Apt W, Miles MA. The ecology of Chagas disease in Chile. Ecol Dis 1982;1:117-29.
20. Schenone H, Villarroel F, Alfaro E. Epidemiology of Chagas disease in Chile. Housing conditions related to the presence of Triatoma infestans and the rate of humans and animals infected by Trypanosoma cruzi. Bol Chil Parasitol 1978;33:2-7.
21. Schenone H, Carrasco J, Dedios F, et al. [Determination of the southern limit of dispersion of domiciliary Triatoma infestation and trypanosomal infection in Chile]. Bol Chil Parasitol 1961;16:59-62.
22. Fearon MA, Scalia V, Huang M, Dines I, Ndao M, Lagacé-Wiens P. A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada. Can J Infect Dis Med Microbiol 2013;24:32-4.
23. Jackson Y, Myers C, Diana A, et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis 2009;15:601-3.
24. Munoz J, Coll O, Juncosa T, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis 2009;48:1736-40.
25. Revista da Sociedade Brasileira de Medicina Tropical - International Colloquium. Congenital infection with Trypanosoma cruzi: From mechanisms of transmission to strategies for diagnosis and control. Rev Soc Bras Med Trop 2003;36:767-71.
26. Carlier Y, Torrico F, Sosa-Estani S, et al. Congenital Chagas disease: Recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women. PLoS Negl Trop Dis 2011;5:e1250.
27. Bern C MSPHBL, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: A systematic review. JAMA 2007;298:2171-81.
28. Rodriques Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002;97:3-24.
29. Altcheh J, Biancardi M, Lapena A, Ballering G, Freilij H. Congenital Chagas disease: Experience in the Hospital de Ninos, Ricardo Gutierrez, Buenos Aires, Argentina. Rev Soc Bras Med Trop 2005;38 Suppl 2:41-5.30.
30. Bern C. Antitrypanosomal therapy for chronic Chagas disease. N Engl J Med. 2011;364:2527-34.
31. Viotti R, Alarcón de Noya B, Araujo-Jorge T, et al; Latin American Network for Chagas Disease, NHEPACHA. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother 2014;58:635-9.
32. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.
33. Marin-Neto JA, Rassi A Jr, Avezum A Jr, et al. The BENEFIT trial: Testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz 2009;104(Suppl 1):319-24.
34. Molina I, Gómez i Prat J, Salvador F, et al. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. N Engl J Med 2014;370:1899-908.